News

In addition, in post hoc analyses, ANX-530 demonstrated a statistically significant reduction in injection site reactions when compared to Navelbine (p

The new patent claims cover the culture and derivation of embryonic stem (ES) cells using a medium that contains leukemia inhibitory factor (LIF) and an inhibitor of an

According to the company, the CTC Advance microwave catheter is the latest advancement in Cooled ThermoTherapy, a customizable and durable nonsurgical treatment for enlarged prostate disease, also known

The new office compliments its UK-based operations and will further enable its sales and professional services teams to readily oversee in-region deployments. The establishment of the European headquarters

Casper previously served as president of Thermo Fisher’s Analytical Technologies businesses following the merger of Thermo Electron and Fisher Scientific in November 2006. Prior to this, Casper served

Harrison’s Practice, developed by McGraw-Hill Professional, a global provider of information resources for the scientific and medical communities, was created by the editors of Harrison’s Principles of Internal

The collaboration, announced in May 2006, has a maximum term of 5 years until 2011 and may be extended by Schering-Plough after each single year. Under the agreement,

In accordance with the agreement between the two parties, Medicis will pay Ipsen approximately $25 million and subject to approval of the biologics license application by the FDA,

UCL (University College London) has an ongoing drug discovery program for the treatment of vascular collapse during sepsis (collapsing of blood vessels due to systemic infection by a